(Q54652333)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Tamás Masszi

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

H Andrikovics

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

S Nahajevszky

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

M Koszarska

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

N Meggyesi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A Bors

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

G Halm

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

S Lueff

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

N Lovas

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Z Matrai

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

J Csomor

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

R Rasonyi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

M Egyed

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

J Varkonyi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

G Mikala

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A Sipos

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A Kozma

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

E Adam

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

S Fekete

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A Tordai

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

2 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

1809-1813

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20811399%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2010.172

13 February 2020

exact match

0 references

cites work

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.172

A germline JAK2 SNP is associated with predisposition to the development of JAK2(V617F)-positive myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.172

JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.172

The JAK2 46/1 haplotype confers susceptibility to essential thrombocythemia regardless of JAK2V617F mutational status-clinical correlates in a study of 226 consecutive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.172

JAK2 germline genetic variation affects disease susceptibility in primary myelofibrosis regardless of V617F mutational status: nullizygosity for the JAK2 46/1 haplotype is associated with inferior survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.172

MPL mutation effect on JAK2 46/1 haplotype frequency in JAK2V617F-negative myeloproliferative neoplasms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.172

The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.172

Somatic and germline genetics at the JAK2 locus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.172

Frequency and clinical correlates of JAK2 46/1 (GGCC) haplotype in primary myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.172